Glympse Bio Company
Glympse Bio develops a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis.Glympse Bio - Crunchbase Company Profile & Fundingwww.crunchbase.com/organization/glympse-bioWas this helpful?
Investors
Total Funding:
93299987.0
Headquarters:
Cambridge, Massachusetts, United States
Estimated Revenue:
$1M to $10M
Last Funding Type:
Venture - Series Unknown
Technology:
['BioTech & HealthTech']
Last Funding Date:
2021-12-17
Investors Number:
17.0
Founded Date:
2015-01-01
Industry:
Medical BioTech